Cost‐Effectiveness of Automated Insulin Delivery Systems in Paediatrics, <scp>T1D</scp> and <scp>T2D</scp> Adults Across Four Nordic Countries

AID therapy consistently projected reduced diabetes-related complications while remaining cost-effective across a broad spectrum of diabetes patient profiles in the Nordic region. These findings strengthen the case towards widespread integration of AID technology into national diabetes care frameworks.